Article Information
History
- February 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Muanpetch Rachayon1,
- Ketsupar Jirakran1,
- Pimpayao Sodsai2,
- Siriwan Klinchanhom3,
- Atapol Sughondhabirom1,
- Kitiporn Plaimas4,
- Apichat Suratanee5 and
- Michael Maes1,6,7,*
- 1Department of Psychiatry, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand
- 2Center of Excellence in Immunology and Immune-Mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 3Division of Immunology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 4Advanced Virtual and Intelligent Computing (AVIC) Center, Department of Mathematics and Computer Science, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand
- 5Department of Mathematics, Faculty of Applied Science, King Mongkut’s University of Technology North Bangkok, Bangkok 10800, Thailand
- 6IMPACT Strategic Research Center, Barwon Health, Geelong, Australia
- 7Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria
- ↵*Corresponding author: Prof. Dr Michael Maes, M.D., PhD. Department of Psychiatry, Faculty of Medicine, Chulalongkorn University Bangkok, 10330, Thailand, Email: dr.michaelmaes{at}hotmail.com, Michael Maes - Google Scholar
Posted February 06, 2022.
Effects of cannabidiol on activated immune-inflammatory pathways in major depressive patients and healthy controls
